208 related articles for article (PubMed ID: 9795764)
1. The functional significance of epitope spreading and its regulation by co-stimulatory molecules.
Vanderlugt CL; Begolka WS; Neville KL; Katz-Levy Y; Howard LM; Eagar TN; Bluestone JA; Miller SD
Immunol Rev; 1998 Aug; 164():63-72. PubMed ID: 9795764
[TBL] [Abstract][Full Text] [Related]
2. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.
Neville KL; Dal Canto MC; Bluestone JA; Miller SD
J Virol; 2000 Sep; 74(18):8349-57. PubMed ID: 10954534
[TBL] [Abstract][Full Text] [Related]
3. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD
J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774
[TBL] [Abstract][Full Text] [Related]
4. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
5. Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice.
Katz-Levy Y; Neville KL; Padilla J; Rahbe S; Begolka WS; Girvin AM; Olson JK; Vanderlugt CL; Miller SD
J Immunol; 2000 Nov; 165(9):5304-14. PubMed ID: 11046065
[TBL] [Abstract][Full Text] [Related]
6. Functional activation of myelin-specific T cells by virus-induced molecular mimicry.
Olson JK; Eagar TN; Miller SD
J Immunol; 2002 Sep; 169(5):2719-26. PubMed ID: 12193746
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytes from mice chronically infected with Theiler's murine encephalomyelitis virus produce demyelination of organotypic cultures after stimulation with the major encephalitogenic epitope of myelin proteolipid protein. Epitope spreading in TMEV infection has functional activity.
Dal Canto MC; Calenoff MA; Miller SD; Vanderlugt CL
J Neuroimmunol; 2000 Apr; 104(1):79-84. PubMed ID: 10683517
[TBL] [Abstract][Full Text] [Related]
8. Theiler's virus-mediated autoimmunity: local presentation of CNS antigens and epitope spreading.
Tompkins SM; Fuller KG; Miller SD
Ann N Y Acad Sci; 2002 Apr; 958():26-38. PubMed ID: 12021081
[TBL] [Abstract][Full Text] [Related]
9. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.
McMahon EJ; Bailey SL; Castenada CV; Waldner H; Miller SD
Nat Med; 2005 Mar; 11(3):335-9. PubMed ID: 15735651
[TBL] [Abstract][Full Text] [Related]
10. Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virus-induced demyelinating diseases.
Miller SD; Eagar TN
Adv Exp Med Biol; 2001; 490():99-107. PubMed ID: 11505979
[TBL] [Abstract][Full Text] [Related]
11. Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler's virus infection of the central nervous system.
Miller SD; Katz-Levy Y; Neville KL; Vanderlugt CL
Adv Virus Res; 2001; 56():199-217. PubMed ID: 11450300
[TBL] [Abstract][Full Text] [Related]
12. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE.
Miller SD; Vanderlugt CL; Lenschow DJ; Pope JG; Karandikar NJ; Dal Canto MC; Bluestone JA
Immunity; 1995 Dec; 3(6):739-45. PubMed ID: 8777719
[TBL] [Abstract][Full Text] [Related]
13. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
[TBL] [Abstract][Full Text] [Related]
14. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading.
Miller SD; Vanderlugt CL; Begolka WS; Pao W; Yauch RL; Neville KL; Katz-Levy Y; Carrizosa A; Kim BS
Nat Med; 1997 Oct; 3(10):1133-6. PubMed ID: 9334726
[TBL] [Abstract][Full Text] [Related]
15. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.
Miller SD; Gerety SJ; Kennedy MK; Peterson JD; Trotter JL; Tuohy VK; Waltenbaugh C; Dal Canto MC; Lipton HL
J Neuroimmunol; 1990 Jan; 26(1):9-23. PubMed ID: 1688446
[TBL] [Abstract][Full Text] [Related]
16. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
Gerety SJ; Rundell MK; Dal Canto MC; Miller SD
J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740
[TBL] [Abstract][Full Text] [Related]
17. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis.
Mack CL; Vanderlugt-Castaneda CL; Neville KL; Miller SD
J Neuroimmunol; 2003 Nov; 144(1-2):68-79. PubMed ID: 14597100
[TBL] [Abstract][Full Text] [Related]
18. Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler's virus infection.
Miller SD; Olson JK; Croxford JL
J Autoimmun; 2001 May; 16(3):219-27. PubMed ID: 11334486
[TBL] [Abstract][Full Text] [Related]
19. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases.
Miller SD; McRae BL; Vanderlugt CL; Nikcevich KM; Pope JG; Pope L; Karpus WJ
Immunol Rev; 1995 Apr; 144():225-44. PubMed ID: 7590815
[TBL] [Abstract][Full Text] [Related]
20. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
